US listed Abbott Laboratories shares jumped 12% after the healthcare company reported stronger second-quarter sales and raised its full-year earnings outlook. The company said second-quarter sales rose 13% on a reported basis and 4.8% on a comparable basis.
Abbott reported GAAP diluted earnings per share of $0.53, while adjusted diluted earnings per share came in at $1.31, excluding specified items. The company also raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.45 to $5.60. The company had earlier guided for adjusted EPS of $5.38 to $5.58. It reaffirmed its full-year comparable sales growth guidance of 6.5% to 7.5%.
